GENinCode Plc (LON:GENI – Get Free Report)’s stock price traded down 3.6% during trading on Friday . The stock traded as low as GBX 3.86 ($0.05) and last traded at GBX 4 ($0.05). 82,396 shares changed hands during trading, a decline of 59% from the average session volume of 203,110 shares. The stock had previously closed at GBX 4.15 ($0.05).
GENinCode Trading Down 3.6 %
The company has a current ratio of 2.60, a quick ratio of 15.89 and a debt-to-equity ratio of 9.27. The stock has a market capitalization of £7.08 million, a P/E ratio of -80.00 and a beta of 0.66. The business’s fifty day simple moving average is GBX 5.15 and its two-hundred day simple moving average is GBX 6.38.
About GENinCode
GENinCode Plc develops and commercializes clinical genetic tests to provide predictive analysis of risk to a patient's health based on their genes in the United Kingdom and internationally. Its predictive technology provides patients and physicians with preventative care and treatment strategies.
Read More
- Five stocks we like better than GENinCode
- Russell 2000 Index, How Investors Use it For Profitable Trading
- How Whitestone REIT Is Transforming Sun Belt Retail Growth
- Bank Stocks – Best Bank Stocks to Invest In
- Top-Performing Non-Leveraged ETFs This Year
- Why Special Dividends Can be a Delightful Surprise for Income Investors
- Rivian’s Wild Ride: Is the Dip a Buying Opportunity?
Receive News & Ratings for GENinCode Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GENinCode and related companies with MarketBeat.com's FREE daily email newsletter.
